Time-related factors predicting a positive response to cardiac resynchronisation therapy in patients with heart failure.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 05 2023
Historique:
received: 08 01 2023
accepted: 14 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 26 5 2023
Statut: epublish

Résumé

This study aimed to identify time parameters predicting favourable CRT response. A total of 38 patients with ischemic cardiomyopathy, qualified for CRT implantation, were enrolled in the study. A 15% reduction in indexed end-systolic volume after 6 months was a criterion for a positive response to CRT. We evaluated QRS duration, measured from a standard ECG before and after CRT implantation and obtained from mapping with NOGA XP system (AEMM); and the delay, measured with the implanted device algorithm (DCD) and its change after 6 months (ΔDCD); and selected delay parameters between the left and right ventricles based on AEMM data. A total of 24 patients presented with a positive response to CRT versus 9 non-responders. After CRT implantation, we observed differences between responders and non-responders group in the reduction of QRS duration (31 ms vs. 16 ms), duration of paced QRS (123 ms vs. 142 ms), and the change of ΔDCDMaximum (4.9 ms vs. 0.44 ms) and ΔDCDMean (7.7 ms vs. 0.9 ms). The difference in selected parameters obtained during AEMM in both groups was related to interventricular delay (40.3 ms vs. 18.6 ms). Concerning local activation time and left ventricular activation time, we analysed the delays in individual left ventricular segments. Predominant activation delay of the posterior wall middle segment was associated with a better response to CRT. Some AEMM parameters, paced QRS time of less than 120 ms and reduction of QRS duration greater than 20 ms predict the response to CRT. ΔDCD is associated with favourable electrical and structural remodelling.Clinical trial registration: SUM No. KNW/0022/KB1/17/15.

Identifiants

pubmed: 37237039
doi: 10.1038/s41598-023-35174-9
pii: 10.1038/s41598-023-35174-9
pmc: PMC10219980
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8524

Informations de copyright

© 2023. The Author(s).

Références

Pacing Clin Electrophysiol. 2021 Sep;44(9):1532-1539
pubmed: 34374444
J Cardiovasc Electrophysiol. 2009 Jul;20(7):764-8
pubmed: 19298563
Medicina (Kaunas). 2022 Dec 12;58(12):
pubmed: 36557030
Europace. 2019 Feb 01;21(2):281-289
pubmed: 30403774
J Am Coll Cardiol. 2022 Sep 27;80(13):1205-1216
pubmed: 36137670
JACC Clin Electrophysiol. 2017 Aug;3(8):854-862
pubmed: 29759782
Int J Cardiol. 2016 Dec 15;225:345-352
pubmed: 27756040
BMC Cardiovasc Disord. 2012 May 20;12:34
pubmed: 22607487
J Innov Card Rhythm Manag. 2018 Jan 15;9(1):2989-2995
pubmed: 32477783
J Am Coll Cardiol. 2012 Apr 24;59(17):1509-18
pubmed: 22405632
N Engl J Med. 2009 Oct 1;361(14):1329-38
pubmed: 19723701
J Atr Fibrillation. 2015 Apr 30;7(6):1214
pubmed: 27957163
JACC Clin Electrophysiol. 2022 Jan;8(1):59-69
pubmed: 34454880
Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006055
pubmed: 30354310
Circ Arrhythm Electrophysiol. 2013 Aug;6(4):682-9
pubmed: 23873141
Front Physiol. 2019 Feb 11;10:74
pubmed: 30804805
Heart Rhythm. 2017 Dec;14(12):1748-1755
pubmed: 29195547
Eur Heart J. 2012 Nov;33(21):2662-71
pubmed: 22285578
Circ Arrhythm Electrophysiol. 2014 Jun;7(3):377-83
pubmed: 24668162
Eur Heart J. 2011 Oct;32(20):2516-24
pubmed: 21875862
Circ J. 2014;78(1):71-7
pubmed: 24162927
J Cardiovasc Transl Res. 2016 Aug;9(4):257-65
pubmed: 27230674
Eur Heart J. 2021 Sep 14;42(35):3427-3520
pubmed: 34455430
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Eur J Heart Fail. 2014 Nov;16(11):1214-22
pubmed: 25315161
Heart. 2019 Jan;105(2):137-143
pubmed: 30093543
Europace. 2016 Apr;18(4):550-9
pubmed: 26116830
JACC Clin Electrophysiol. 2021 Nov;7(11):1422-1432
pubmed: 34167929
Heart Rhythm. 2020 Nov;17(11):1870-1877
pubmed: 32470623

Auteurs

Jacek Wilczek (J)

Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland. jwilczek@sum.edu.pl.
Electrocardiology Department, Upper Silesian Medical Center, Katowice, Poland. jwilczek@sum.edu.pl.

Tomasz Jadczyk (T)

Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
Third Department of Cardiology, Upper Silesian Medical Center, Katowice, Poland.
Interventional Cardiac Electrophysiology Group, International Clinical Research Center, St. Anne's University Hospital in Brno, Brno, Czech Republic.

Wojciech Wojakowski (W)

Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
Third Department of Cardiology, Upper Silesian Medical Center, Katowice, Poland.

Krzysztof S Gołba (KS)

Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland.
Electrocardiology Department, Upper Silesian Medical Center, Katowice, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH